These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18548199)

  • 21. Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources.
    Zień P; Bretner M; Zastapiło K; Szyszka R; Shugar D
    Biochem Biophys Res Commun; 2003 Jun; 306(1):129-33. PubMed ID: 12788077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TBBz but not TBBt discriminates between two molecular forms of CK2 in vivo and its implications.
    Zień P; Abramczyk O; Domańska K; Bretner M; Szyszka R
    Biochem Biophys Res Commun; 2003 Dec; 312(3):623-8. PubMed ID: 14680810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isomeric mono-, di-, and tri-bromobenzo-1H-triazoles as inhibitors of human protein kinase CK2α.
    Wąsik R; Wińska P; Poznański J; Shugar D
    PLoS One; 2012; 7(11):e48898. PubMed ID: 23155426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 inhibitors.
    Martínez R; Geronimo BD; Pastor M; Zapico JM; Coderch C; Panchuk R; Skorokhyd N; Maslyk M; Ramos A; de Pascual-Teresa B
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32218358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetoxymethyl Ester of Tetrabromobenzimidazole-Peptoid Conjugate for Inhibition of Protein Kinase CK2 in Living Cells.
    Viht K; Saaver S; Vahter J; Enkvist E; Lavogina D; Sinijärv H; Raidaru G; Guerra B; Issinger OG; Uri A
    Bioconjug Chem; 2015 Dec; 26(12):2324-35. PubMed ID: 26559659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells.
    Kaminska B; Ellert-Miklaszewska A; Oberbek A; Wisniewski P; Kaza B; Makowska M; Bretner M; Kazimierczuk Z
    Int J Oncol; 2009 Nov; 35(5):1091-100. PubMed ID: 19787263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.
    Janeczko M; Orzeszko A; Kazimierczuk Z; Szyszka R; Baier A
    Eur J Med Chem; 2012 Jan; 47(1):345-50. PubMed ID: 22115617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
    Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
    Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.
    Pagano MA; Andrzejewska M; Ruzzene M; Sarno S; Cesaro L; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Pinna LA
    J Med Chem; 2004 Dec; 47(25):6239-47. PubMed ID: 15566294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells.
    Wińska P; Skierka K; Łukowska-Chojnacka E; Koronkiewicz M; Cieśla J; Bretner M
    Anticancer Res; 2018 Aug; 38(8):4617-4627. PubMed ID: 30061228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermodynamic parameters for binding of some halogenated inhibitors of human protein kinase CK2.
    Winiewska M; Makowska M; Maj P; Wielechowska M; Bretner M; Poznański J; Shugar D
    Biochem Biophys Res Commun; 2015 Jan; 456(1):282-7. PubMed ID: 25450618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzimidazole inhibitors of protein kinase CK2 potently inhibit the activity of atypical protein kinase Rio1.
    Kubiński K; Masłyk M; Orzeszko A
    Mol Cell Biochem; 2017 Feb; 426(1-2):195-203. PubMed ID: 27909846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro.
    Schneider CC; Kartarius S; Montenarh M; Orzeszko A; Kazimierczuk Z
    Bioorg Med Chem; 2012 Jul; 20(14):4390-6. PubMed ID: 22698781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro.
    Lawnicka H; Kowalewicz-Kulbat M; Sicinska P; Kazimierczuk Z; Grieb P; Stepien H
    Cell Tissue Res; 2010 May; 340(2):371-9. PubMed ID: 20383646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2.
    Guillon J; Le Borgne M; Rimbault C; Moreau S; Savrimoutou S; Pinaud N; Baratin S; Marchivie M; Roche S; Bollacke A; Pecci A; Alvarez L; Desplat V; Jose J
    Eur J Med Chem; 2013 Jul; 65():205-22. PubMed ID: 23711832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and activity of 1H-benzimidazole and 1H-benzotriazole derivatives as inhibitors of Acanthamoeba castellanii.
    Kopańska K; Najda A; Zebrowska J; Chomicz L; Piekarczyk J; Myjak P; Bretner M
    Bioorg Med Chem; 2004 May; 12(10):2617-24. PubMed ID: 15110843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of 1H-benzotriazole and 1H-benzimidazole analogues--inhibitors of the NTpase/helicase of HCV and of some related Flaviviridae.
    Bretner M; Baier A; Kopańska K; Najda A; Schoof A; Reinholz M; Lipniacki A; Piasek A; Kulikowski T; Borowski P
    Antivir Chem Chemother; 2005; 16(5):315-26. PubMed ID: 16245647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multisite-directed inhibitors of protein kinase CK2: new challenges.
    Świder R; Masłyk M; Martín-Santamaría S; Ramos A; de Pascual-Teresa B
    Mol Cell Biochem; 2011 Oct; 356(1-2):117-9. PubMed ID: 21750979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.